Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Patient-Centered Guidance Educate on transient issues, track symptoms, and personalise plans
In a head-to-head study in adults with type 2 diabetes, Victoza demonstrated powerful A1C reductions after patients switched from Januvia 4 Primary endpoint: Mean change in A1C from baseline After 26 weeks Switch to Victoza after Januvia after Januvia Bailey (LIRA-SWITCH) Baseline A1C: 8.2% to 8.3% Studied in adults with type 2 diabetes taking metformin
Vas de administracin en investigacin : Subcutnea : va preferente para protocolos sistmicos
Water intake: validity of population assessment and recommendations
US$ 23.92
US$ 26.29
US$ 26.85
US$ 26.80
US$ 25.35
